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-Spectrin and ankyrin are major components of the
membrane cytoskeleton. We have generated mice
 
carrying a null mutation in the 
 
 
 
IV-spectrin
 
 gene
using gene trapping in embryonic stem cells. Mice
homozygous for the mutation exhibit tremors and contraction
of hindlimbs. 
 
 
 
IV-spectrin expression is mostly restricted to
neurons, where it colocalizes with and binds to ankyrin-G
at axon initial segments (AISs) and nodes of Ranvier
 
(NR). In 
 
 
 
IV-spectrin
 
–null neurons, neither ankyrin-G nor
 
 
voltage-gated sodium channels (VGSC) are correctly
clustered at these sites, suggesting that impaired action
potential caused by mislocalization of VGSC leads to the
 
phenotype. Conversely, in 
 
ankyrin-G
 
–null neurons, 
 
 
 
IV-
spectrin is not localized to these sites. These results indicate
that 
 
 
 
IV-spectrin and ankyrin-G mutually stabilize the mem-
brane protein cluster and the linked membrane cytoskeleton
at AIS and NR.
 
Introduction
 
The axons of myelinated neurons are wrapped with myelin
sheaths produced by oligodendrocytes in the central nervous
system, and by Schwann cells in the peripheral nervous system
(for review see Arroyo and Scherer, 2000). The insulating
property of the sheath facilitates a rapid and efficient
propagation of the action potential through the axon (for
review see Vabnick and Shrager, 1998). Two sites not
wrapped by myelin are the axon initial segment (AIS)* and
the node of Ranvier (NR). The AIS is the part of the axon
between the cell body and the beginning of the myelin
sheath, and the NR is a site of discontinuity between succes-
sive myelin sheaths along the axon (for review see Arroyo
and Scherer, 2000; Peles and Salzer, 2000). Both of these
sites are polarized structures where the same membrane
proteins are clustered. These proteins include voltage-gated
sodium channels (VGSCs), the cell adhesion molecules neu-
rofascin and NrCAM, and the membrane skeletal protein
ankyrin-G (for review see Bennett and Lambert, 1999).
VGSC, neurofascin, and NrCAM all bind through their cy-
toplasmic domains to ankyrin-G (Srinivasan et al., 1988;
Davis et al., 1996). VGSCs are responsible for producing
the inward ionic flow to generate the action potential at AIS
and to maintain the action potential at NR. In addition,
these clustered proteins at AIS, together with the linked
spectrin-actin membrane cytoskeleton, may function as a
diffusion barrier that prevents axonal proteins from leaking
out to the cell body (Winckler et al., 1999).
The mechanisms by which these specific membrane pro-
teins are concentrated at AIS and NR are not yet understood.
A number of in vivo and in vitro studies have implicated my-
elinating glial cells in localizing axonal membrane proteins to
NR both in the central and peripheral nervous systems (for
review see Peles and Salzer, 2000; Rasband and Trimmer,
2001). Several axonal proteins have also been implicated in
this process. It has been suggested that neurofascin and
NrCAM may have a role in defining the initial sites for clus-
tering in rat sciatic nerves, because clustering of these cell ad-
hesion molecules precedes that of ankyrin-G and VGSC as
well as myelination of the axon (Lambert et al., 1997).
However, in cerebellar Purkinje cells of 
 
ankyrin-G
 
 knockout
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mice, clustering of neurofascin as well as VGSC at AIS is
disrupted, leading to a failure in normal action potential fir-
ing (Zhou et al., 1998). These results indicate that ankyrin-
G is an essential component for localizing neurofascin and
VGSC at these sites. Taken together, these observations sug-
gest that the membrane protein clustering is a sequential
process that includes glial and axonal proteins, and that the
factors defining the site of protein clustering and the factors
stabilizing the once-formed cluster are distinct.
Ankyrins are linked to the spectrin-actin membrane cy-
toskeleton through binding to 
 
 
 
-spectrins (Davis and Ben-
nett, 1990; Kennedy et al., 1991). Therefore, it is possible
that the membrane cytoskeleton at AIS and NR binds
ankyrin-G and defines the localization of associated mem-
brane proteins. Indeed, it has been shown that the putative
 
 
 
-spectrin–binding domain of ankyrin-G alone can be tar-
geted to AIS in cultured neurons (Zhang and Bennett,
1998). As 
 
 
 
II-spectrin is localized to axons (whereas 
 
 
 
I
 
 
 
2-
and 
 
 
 
III-spectrins are localized to the cell body and den-
drites in neurons) (Riederer et al., 1986; Ohara et al., 1998),
 
 
 
II-spectrin has been believed to bind ankyrin-G at AIS and
NR. However, it has not been thought to be involved in de-
fining the localization of ankyrin-G, as it is present through-
out the axon (Riederer et al., 1986). Recently, a new mem-
ber of the 
 
 
 
-spectrin family, 
 
 
 
IV-spectrin, has been
identified (Berghs et al., 2000; Tse et al., 2001). This pro-
tein was shown to colocalize with ankyrin-G at AIS and NR
(Berghs et al., 2000), raising the possibility that this novel
 
 
 
-spectrin might bind ankyrin-G and thus be involved in
clustering ankyrin-G and associated membrane proteins.
Using gene trap mutagenesis to identify and mutate genes
regulated by retinoic acid (Komada et al., 2000), we have
identified the ROSA62 mouse strain that harbors a null mu-
tation in the 
 
 
 
IV-spectrin
 
 gene. ROSA62 mice exhibit trem-
ors and hindlimb contraction, and the phenotype increases
in severity with age. We demonstrate that 
 
 
 
IV-spectrin plays
an essential role in localizing ankyrin-G and VGSC at AIS
and NR in neurons. Conversely, we show that 
 
 
 
IV-spectrin
localization to AIS requires ankyrin-G, indicating a mutual
role for 
 
 
 
IV-spectrin and ankyrin-G in stabilizing the mem-
brane protein cluster and the linked membrane skeleton at
these sites. Very recently, Parkinson et al. (2001) showed
that the spontaneous mouse mutant, 
 
quivering
 
 (
 
qv
 
) (Yoon
and Les, 1957), carries a mutation in the 
 
 
 
IV-spectrin
 
 gene.
We propose that the phenotype of ROSA62 and 
 
qv
 
 mice is
primarily due to mislocalization of VGSC at AIS and NR.
 
Results
 
We have screened for retinoic acid–inducible gene trapping
in mouse embryonic stem (ES) cells using the retroviral vec-
tor ROSA
 
 
 
geo*, which transduces a promoterless 
 
 
 
geo*
 
 (a
fusion gene of 
 
 
 
-galactosidase
 
 and 
 
neomycin phosphotrans-
ferase II
 
) as a reporter (Komada et al., 2000; http://www.
fhcrc.org/labs/soriano/trap.html). Northern blot analysis con-
firmed that one of the lines, ROSA62, exhibited a 17-fold
induction of the reporter gene expression after 6-h treatment
with 1 
 
 
 
M all-trans retinoic acid (unpublished data). This
strong induction led us to characterize the gene trap muta-
tion in detail. As the expression of the 
 
ROSA62
 
 gene is
 
mostly restricted to neurons in mice (see below), this induc-
tion might reflect the ability of retinoic acid to induce neu-
ronal differentiation of ES cells.
 
Neuromuscular defects in ROSA62 mutant mice
 
Germline chimeric mice were generated by injecting ROSA62
mutant ES cells into blastocysts, and were crossed to 129/S4
and C57BL/6J mice to derive mutants. Heterozygotes exhib-
ited no overt phenotype. Viable homozygous mutant mice
were recovered from intercrossing of heterozygotes according
to Mendelian expectations and were mostly of normal size.
However, by 3 wk of age, homozygous mutants were distin-
guishable from wild-type and heterozygous mutant littermates
by fine tremors. Until 2–3 mo of age, the homozygotes were
grossly normal except for the tremor. They also exhibited
clasping of the hindlimbs when held by the tail, a hallmark of
ataxia. As they grew older, the phenotype became more severe.
By 6–10 mo of age, they exhibited continuous contraction of
hindlimb skeletal muscle and were not able to walk. The same
phenotype was observed on congenic 129/S4, mixed 129/S4 x
C57BL/6J, and congenic C57BL/6J (
 
 
 
10-generation back-
cross) genetic background. The following analyses were per-
formed on mixed 129/S4x C57BL/6J genetic background.
 
Expression pattern of the 
 
ROSA62
 
 gene in mice
 
Expression of 
 
 
 
-galactosidase activity in gene trap mutant
mice is driven by the promoter of the trapped gene
(Friedrich and Soriano, 1991). Therefore, ROSA62 het-
erozygous mutant embryos and adult tissues were isolated
and stained with X-gal to determine the expression pattern
of the trapped gene.
In embryonic day 10.5 embryos, expression was restricted
to cranial and dorsal root ganglia (Fig. 1 A). In adult mice,
expression was detected in many regions of the brain, with
the highest level in the hippocampus and cerebellum (Fig. 1
B). Expression was also detected in the spinal cord (Fig. 1
C). In contrast, no 
 
 
 
-galactosidase activity was detected in
skeletal muscle (unpublished data), suggesting that the phe-
notype of ROSA62 mutant mice is primarily due to a defect
in neurons but not skeletal muscle.
Other than the neuronal tissues, 
 
ROSA62
 
 expression was
detected in the pancreas (Fig. 1 D) and testis (Fig. 1 E), but
not in the heart, lung, liver, kidney, spleen, stomach, small
intestine, colon, ovary, and uterus (unpublished data). In
the pancreas, expression was restricted to the islet of Langer-
hans (Fig. 1 D), whereas in the testis, it was detected in
round and elongated spermatids (Fig. 1 E). However, no
histological abnormalities were observed in any of these tis-
sues of the homozygotes (unpublished data). The homozy-
gous mutant males reproduced very inefficiently when
mated with wild-type females. However, this is likely to re-
flect a mating problem as litter sizes were normal.
 
Mutation in 
 
 
 
IV-spectrin
 
 in ROSA62 mutant mice
 
To identify the gene trapped in this mutant, the 
 
ROSA62–
 
 
 
geo*
 
 fusion cDNA was cloned from ROSA62 mutant ES
cells by 5
 
 
 
-RACE, and full-length cDNAs were subsequently
cloned by screening cDNA libraries. Sequencing of the
cDNAs revealed that the trapped gene encodes 
 
 
 
IV-spectrin, 
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Figure 1.  Expression pattern of 
the ROSA62 gene in mice. Expression 
pattern of the ROSA62 gene was 
assessed by X-gal staining of heterozygous 
mutant mice. (A) Embryonic day 10.5 
embryo. Expression is detected in the 
dorsal root ganglia (DRG) and trigeminal 
ganglia (TG). (B) Adult brain. High level 
of expression is detected in the hippo-
campus (HC) and cerebellum (CL). (C) 
Adult spinal cord. GM, gray matter; 
WM, white matter. (D) Adult pancreas. 
Expression is restricted to the islets of 
Langerhans (L). (E) Adult testis. Expression 
is restricted to the round spermatids (RS) 
and elongated spermatids (ES) facing the 
lumen (lu) of the seminiferous tubule. 
Bars: (A and C) 500  m; (B) 1 mm ; (D) 
100  m; (E) 30  m .
Figure 2. Characterization of  IV-spectrin and its gene products. (A) Schematic diagram of the  IV 1- and  6-spectrin isoforms. The gene 
trap vector was inserted between exons encoding the spectrin repeat 12 of the  IV-spectrin gene. (B) Sequence of the 5  region of  IV 6-spectrin 
cDNA and its comparison with the corresponding region of  IV 1-spectrin cDNA. The sequence of  6 diverges upstream of the nucleotide 
4079 of  1 (arrow). (C) Northern blot analysis of  IV-spectrin expression in brains from wild-type ( / ), heterozygous ( / ), and homozygous 
( / ) mutant mice. The regions of the 5 - and 3 -probes are indicated in (A). Positions of the 28S and 18S rRNAs are indicated. (D) Western 
blot analysis of  IV-spectrin in brain lysates from wild-type ( / ), heterozygous ( / ), and homozygous ( / ) mutant mice. Positions of size 
markers are indicated in kD on the left. The sequence data are available from Genbank/EMBL/DDBJ accession no. AB055618 for  IV 1-spectrin 
and AB055619–AB055621 for  IV 6-spectrin. 
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for which the human homologue has been recently identified
(Berghs et al., 2000; Tse et al., 2001). Two 
 
 
 
IV-spectrin
splice isoforms, 
 
 
 
1 and 
 
 
 
6, were cloned (Fig. 2 A). 
 
 
 
IV
 
 
 
1-
spectrin was 2561 amino acids long, consisted of an NH
 
2
 
-ter-
minal actin-binding domain, 17 spectrin repeats, a variable
region, and a COOH-terminal plecstrin homology (PH)
domain, and had 95% overall sequence identity to its human
homologue. The actin-binding domain, the entire spectrin re-
peats, and the PH domain of 
 
 
 
IV
 
 
 
1-spectrin were 
 
 
 
70, 40,
and 55% identical in amino acid sequences, respectively, to
those of 
 
 
 
I-, 
 
 
 
II-, and 
 
 
 
III-spectrins, with the highest se-
quence identity to 
 
 
 
II-spectrin.
The other isoform has not been identified in human and
was termed 
 
 
 
IV
 
 
 
6-spectrin in this study (
 
 
 
2–5 isoforms
have been reported in humans) (Berghs et al., 2000; Tse et
al., 2001). This novel isoform lacked the NH
 
2
 
-terminal ac-
tin-binding domain, the spectrin repeats 1–9, and part of
spectrin repeat 10 (Fig. 2 A). The 
 
 
 
IV
 
 
 
6-spectrin
 
 cDNA has
a distinct 81-bp sequence upstream of nucleotide 4079 of
 
 
 
IV
 
 
 
1-spectrin
 
, which is derived from an alternative exon
(Fig. 2 B). An in-frame translation stop codon is located 72
bp upstream of the ATG encoding methionine 1321 of the
 
 
 
1 isoform, suggesting that this ATG is used as an transla-
tion initiation codon for 
 
 
 
IV
 
 
 
6-spectrin
 
 (Fig. 2 B). Two
more distinct 
 
 
 
IV
 
 
 
6-spectrin
 
 cDNAs with a different 5
 
 
 
noncoding region diverging upstream of nucleotide 4079 of
 
 
 
IV
 
 
 
1-spectrin
 
 were also cloned (unpublished data), indi-
cating that the second exon for 
 
 
 
IV
 
 
 
6-spectrin
 
 can be alter-
natively spliced from three distinct first exons. The original
5
 
 
 
-RACE product cloned from ROSA62 mutant ES cells
Figure 3. Subcellular localization of 
 IV-spectrin. Cultured ES cells (A–A   
and B–B  ), dentate gyrus (C–C  ) and 
cerebellum (D–D  ) of the brain, and 
sciatic nerves (E–E  ) were stained with 
anti– IV-spectrin antibody (A, B, C, D, 
and E) together with phalloidin (A ), anti-
vinculin (B’), anti–ankyrin-G (C  and 
D ), and anti-Nav1.6 (E ). (A  , B  , C  , 
D  , and E  ) Merged images. In D  , the 
granular layer (G), Purkinje cell layer (P), 
and molecular layer (M) of the cerebellum 
are separated by dotted lines. Bars: 
(A–A,   B–B,   and E–E  ) 30  m; (C–C   
and D–D  ) 100  m. 
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encoded the 
 
 
 
6 isoform, and its sequence indicated that the
gene trap vector was inserted between exons that encode the
spectrin repeat 12 of 
 
 
 
IV
 
 
 
1-spectrin (Fig. 2 A). We did not
isolate cDNAs encoding the 
 
 
 
2, 
 
 
 
3, 
 
 
 
4, and 
 
 
 
5 isoforms
identified in human.
 
Expression of 
 
 
 
IV-spectrin in mice and its absence in 
ROSA62 mutant
 
To determine if the gene trap mutation leads to a null allele,
Northern and Western blot analyses were performed. By
Northern blot analysis with a 
 
 
 
IV-spectrin cDNA fragment
encoding the 3  region (3 -probe in Fig. 2 A), four  IV-spec-
trin transcripts ( 9, 7, 6.5, and 5 kb in size) were detected
in the brain of wild-type and heterozygous mutant mice
(Fig. 2 C). Using a 5 -probe specific to  IV 1-spectrin (Fig.
2 A), only the 9-kb transcript was detected (Fig. 2 C). As the
 1 and  6 cDNAs we cloned are 8.7 and 4.7 kb long,
respectively, mRNAs encoding these isoforms likely corre-
spond to the 9- and 5-kb transcripts, respectively. In the ho-
mozygous mutant, all of the transcripts detected with the
3 -probe were absent (Fig. 2 C). Using the 5 -probe, a tran-
script which is  9 kb in size was detected (unpublished
data). As this transcript did not hybridize with the 3  probe,
it likely represents the fusion transcript between the 5  end
of  IV-spectrin and the reporter. Western blot analysis was
performed using a polyclonal antibody raised against the
variable region of  IV-spectrin which has no homology to
other proteins. In the wild-type brain, the antibody detected
a minor  300-kD band and a major  160-kD band (Fig. 2
D). The faint band of  140 kD may be another splice iso-
form or a degradation product. From the calculated molecu-
lar mass (289 kD for  1 and 141 kD for  6), the  300-
and  160-kD bands most likely correspond to  IV 1- and
 6-spectrins, respectively. Interestingly, the truncated  6
isoform was much highly expressed than the full-length  1
isoform both at the level of mRNA as well as protein. The
same bands were detected in the heterozygotes, but were less
abundant, and they were absent from the homozygous mu-
tant extract (Fig. 2 D). A truncated  IV-spectrin containing
the NH2-terminal portion might conceivably be produced
in the homozygotes. However, the absence of any mRNAs
and proteins detected by the 3  probe and the antibody, re-
spectively, as well as the gene trap insertion site indicates
that it lacks the spectrin repeats 12–17, the variable region,
and the PH domain. Therefore, the gene trap insertion has
most likely created a functionally null allele of the  IV-spec-
trin gene.
Subcellular localization of  IV-spectrin
Although spectrin was originally identified as the major
component of the plasma membrane skeleton, it is also asso-
ciated with various intracellular organelles and is implicated
in maintaining organelle structures and membrane traffick-
ing (for review see De Matteis and Morrow, 2000). There-
fore, subcellular localization of endogenous  IV-spectrin
was examined by immunofluorescence staining first in ES
cells (the only cell line among those tested expressing  IV-
spectrin) using the anti– IV-spectrin antibody. When
plated on gelatinized cover glass, ES cells often formed an
epithelia-like monolayer of cells that adhered to each other.
In these cells, the anti– IV-spectrin antibody stained subdo-
mains of the adherens junctions which were also stained for
F-actin and  -catenin (Fig. 3, A–A  ; unpublished data).
 IV-spectrin completely colocalized with another adherens
junction protein, vinculin (Fig. 3, B-B  ). These results sug-
gest that  IV-spectrin functions as a component of the
plasma membrane skeleton.
To understand the function of  IV-spectrin in physiologi-
cal cell types, its subcellular localization was next examined in
neurons in sections of mouse brain, spinal cord, and sciatic
nerve. In agreement with the X-gal staining pattern of the
heterozygous mutant brain (Fig. 1 B), strong anti– IV-spec-
trin staining was observed in the dentate gyrus (Fig. 3 C) and
cerebellum (Fig. 3 D). This staining pattern coincided with
that of 480/270 kD ankyrin-G (Fig. 3, C  and D ), a marker
of AIS and NR (Kordeli et al., 1995). Colocalization of  IV-
spectrin with ankyrin-G was also detected in neurons in other
regions of the brain and spinal cord (unpublished data). In
sciatic nerves,  IV-spectrin colocalized with Nav1.6, a mem-
ber of the VGSC  -subunit family that is concentrated at NR
(Caldwell et al., 2000; Fig. 3, E-E  ). These results indicate
that  IV-spectrin localizes to AIS and NR of neurons in both
central and peripheral nervous systems.
Binding of  IV-spectrin to ankyrin-G
 I- and  II-spectrins have been shown to bind ankyrin-R
and ankyrin-B (Davis and Bennett, 1990; Kennedy et al.,
Figure 4. Binding of  IV-spectrin to ankyrin. COS-7 cells were 
transfected with Myc-tagged  IV 6-spectrin (Myc- IV 6) together 
with GFP (lanes 1), GFP-tagged 270 kD ankyrin-G (AnkG-GFP; 
lanes 2), or GFP-tagged 220 kD ankyrin-B (AnkB-GFP; lanes 3). Cell 
lysates were immunoprecipitated with anti-GFP (A and D) or anti-
Myc (B and C). Immunoprecipitates were separated by SDS-PAGE 
and immunoblotted with anti-GFP (A and B) or anti-Myc (C and D). 
Positions of size markers are indicated in kD on the left.342 The Journal of Cell Biology | Volume 156, Number 2, 2002
1991). This fact, together with colocalization of  IV-spec-
trin with ankyrin-G at AIS and NR, suggested that  IV-
spectrin might bind ankyrin-G. To test this possibility,
Myc-tagged   IV 6-spectrin (Myc- IV 6) was cotrans-
fected with green fluorescent protein (GFP), GFP-tagged
270-kD ankyrin-G (AnkG-GFP), or GFP-tagged 220-kD
ankyrin-B (AnkB-GFP) into COS-7 cells. Transfected cells
were lysed and immunoprecipitated, and then immunoblot-
ted with anti-Myc or anti-GFP antibody. Whereas Myc-
 IV 6 was expressed at a similar level in the three transfec-
tants (Fig. 4 C), GFP and AnkB-GFP were much more
highly expressed than AnkG-GFP (Fig. 4 A). Consistent
with the presence in  IV 6-spectrin of the spectrin repeat
15, which has been mapped as an ankyrin-binding domain
in  I- and  II-spectrins (Kennedy et al., 1991), the anti-
Myc antibody coprecipitated both AnkG-GFP and AnkB-
GFP but not GFP alone (Fig. 4 B). However, significantly
more AnkG-GFP was brought down than AnkB-GFP (Fig.
4 B). Similarly, AnkG-GFP coprecipitated Myc- IV 6
more efficiently than AnkB-GFP (Fig. 4 D). These results
indicate that  IV-spectrin binds to ankyrin-G with high af-
finity, and to ankyrin-B to a lesser extent.
Clustering of ankyrin-G and VGSC at AIS and NR in 
 IV-spectrin–null neurons
The subcellular localization of  IV-spectrin as well as bind-
ing to ankyrin-G raised the possibility that it is involved in
regulating the localization of ankyrin-G and thus ankyrin-
G-binding membrane proteins to AIS and NR. To test this
possibility, we examined ankyrin-G and VGSC localization
in  IV-spectrin–null neurons.
As expected from the Northern and Western blot analyses
(Fig. 2, C and D), no anti– IV-spectrin staining was de-
tected above background level in the  IV-spectrin mutant
cerebellar Purkinje and hippocampal pyramidal neurons
(Fig. 5, B and D). Compared with wild-type neurons where
ankyrin-G colocalized with  IV-spectrin at AIS (Fig. 5, A,
A , C, C , and E), staining for ankyrin-G was undetectable
or very faint at these sites in most  IV-spectrin–null neurons
(Fig. 5, B , D , and F). In mutant Purkinje cells with faint
anti–ankyrin-G staining, staining was not restricted to the
AIS but was spread over the rest of the axon (unpublished
data). Although anti–ankyrin-G staining was still restricted
to the AIS in some neurons of the mutant, it was much
weaker than in wild-type neurons (Fig. 5, E and F).
Figure 5. Clustering of ankyrin-G at AIS of  IV-spectrin–null cerebellar and hippocampal neurons. Cerebellum (A, A , B, and B ) and 
hippocampus (C, C , D, and D ) of wild-type (A, A , C, and C’) and  IV-spectrin–null (B, B , D, and D ) mice were stained for  IV-spectrin and 
ankyrin-G as indicated. In E and F, Purkinje cells from wild-type (E) and  IV-spectrin–null (F) mice were double stained for ankyrin-G (red) and 
calbindin D-28K to visualize their cell bodies (green), and are shown at higher magnification. The granular layer (G), Purkinje cell layer (P), 
and molecular layer (M) of the cerebellum are separated by dotted lines (A, A , B, and B ), and Purkinje cell bodies (Pu) are indicated in E and 
F. AIS of Purkinje cells are indicated by arrowheads (A, A , E, and F). Arrows in D and D  indicate the pyramidal cell layer of the hippocampus, 
where AIS of pyramidal neurons are detected in wild-type mice (arrowheads in C and C ). Mice were killed at 3 mo of age. Bars, 50  m.Role for  IV-spectrin and ankyrin-G in neurons | Komada and Soriano 343
The localization of VGSC was examined using an anti–
pan-sodium channel antibody that recognizes all the known
vertebrate sodium channel isoforms (Rasband et al., 1999).
In wild-type mice, VGSC colocalized with  IV-spectrin at
AIS of cerebral cortex (Fig. 6, A and A ) and hippocampal
pyramidal (Fig. 6, C and C ) neurons. However, in  IV-
spectrin mutant mice, VGSC staining was very faint in the
cerebral cortex (Fig. 6, B and B ) and mostly undetectable in
the hippocampus (Fig. 6, D and D ). Similar mislocalization
was also observed for a specific sodium channel isoform
Nav1.6 (Fig. 6, F and F ), which normally localizes to AIS in
Purkinje cells (Fig. 6, E and E ; S. Jenkins and V. Bennett,
personal communication).
Next, we examined the localization of Nav1.6 at NR of
the peripheral nervous system. In the  IV-spectrin–null sci-
atic nerves, Nav1.6-positive but  IV-spectrin–negative NR
were detected (Fig. 7, B-B  ). However, the number of
Nav1.6-positive NR was less than in the wild-type littermate
in which the NR were also positive for  IV-spectrin (Fig. 7,
A–A  ). The number of Nav1.6-positive NR was quantified
in sciatic nerve sections of wild-type and the mutant mice.
Counting of nine randomly chosen 0.1-mm
2 fields from
three mice of each genotype revealed that the numbers were
98   23 and 44   15 (mean   SD) per field in the wild-
type and the mutant, respectively (55% reduction in the
mutant; Fig. 7 C). In addition, anti-Nav1.6 staining of the
NR was often fainter in the mutant than in the wild-type
control (Fig. 7, A  and B , insets). Phase contrast micros-
copy showed that the number as well as the morphology of
NR was unaffected in the mutant (unpublished data).
Taken together, these results indicate that normal localiza-
tion of ankyrin-G and VGSC to AIS and NR requires  IV-
spectrin in its membrane skeleton.
Localization of  IV-spectrin at AIS of
ankyrin-G–null neurons
Next, we examined whether localization of  IV-spectrin to
AIS requires ankyrin-G. To test this, we examined the local-
ization of  IV-spectrin in cerebellar neurons of mutant mice
generated by Zhou et al. (1998) in which the cerebellum-
specific form of ankyrin-G is knocked out. Compared with
wild-type cerebellum where AIS of both Purkinje and granu-
lar neurons were positive for ankyrin-G and  IV-spectrin
(Fig. 8, A, A , and D),  IV-spectrin staining as well as
ankyrin-G staining was mostly lost in the knockout mice
(Fig. 8, B, B , and E).  IV-spectrin localization was normal
in the mutant in other regions than the cerebellum, such as
the hippocampus, where ankyrin-G was expressed (Fig. 8, C
and C ; unpublished data), indicating that ankyrin-G is a
prerequisite for the correct  IV-spectrin localization in AIS.
Figure 6. Clustering of VGSC at AIS of  IV-spectrin–null cerebral, 
hippocampal, and cerebellar neurons. Cerebral cortex (A, A , B, 
and B ), hippocampus (C, C , D, and D ), and cerebellum (E, E , F, 
and F ) of wild-type (A, A , C, C , E, and E ) and  IV-spectrin–null 
(B, B , D, D , F, and F ) mice were stained with anti– IV-spectrin (A, 
B, C, D, E, and F) together with anti–pan-sodium channel (pan-SC; 
A , B , C , and D ) or anti-Nav1.6 (E  and F ). Arrowheads indicate 
AIS of cerebral (A, A , and B ), hippocampal pyramidal (C and C ), 
and Purkinje (E and E’) neurons. The granular layer (G), Purkinje cell 
layer (P), and molecular layer (M) of the cerebellum are separated 
by dotted lines (E, E , F, and F ). Mice were killed at 3 mo of age. 
Bars, 20  m.344 The Journal of Cell Biology | Volume 156, Number 2, 2002
Discussion
Cell polarization involves the localization of individual pro-
teins to specific subdomains in the cell and requires addi-
tional protein components to maintain this localization. The
spectrin family is believed to be involved in localizing spe-
cific membrane proteins at specific submembrane domains
(for review, see Drubin and Nelson, 1996). Here, we dem-
onstrate that a new member of the  -spectrin family,  IV,
Figure 7. Clustering of Nav1.6 at NR of 
 IV-spectrin–null sciatic nerves. Double 
staining of wild-type (A, A , and A  ) and 
 IV-spectrin–null (B, B , and B  ) sciatic 
nerves with anti– IV-spectrin (A and B) 
and anti-Nav1.6 (A  and B ) antibodies. 
(A  ) and (B  ) are merged images. 
Arrowheads in A , B , A  , and B   
indicate some of the Nav1.6-positive NR 
which are also positive for  IV-spectrin 
in the wild-type (A). Insets in A  and B  
show enlarged images of typical NR. In 
C, the number of Nav1.6-positive NR in 
wild-type ( / ) and  IV-spectrin–null 
( / ) sciatic nerve sections were quan-
tified. Mean numbers per 0.1 mm
2 field 
are shown with SD (n   9 for each 
genotype). Mice were killed at 3 mo 
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plays an essential role in maintaining localization of specific
membrane proteins to polarized regions of neurons, and that
this regulated localization is essential for normal neurologi-
cal function.
Molecular mechanisms underlying the
 IV-spectrin–null phenotype
Mislocalization of VGSC to AIS and NR in the  IV-spectrin
mutant suggested that the neurological phenotypes of the
mutant are, at least in part, due to impaired firing and prop-
agation of the action potential in the central and peripheral
nervous systems. This is supported by mouse mutants in
which expression or localization of VGSC is affected.
Nav1.6, also called Scn8a, is the major isoform of VGSC
 -subunit localized at AIS and NR of cerebellar neurons as
well as the sciatic nerve (S. Jenkins and V. Bennett, personal
communication; Caldwell et al., 2000). It has been shown
that in mice with mutations in the Nav1.6 gene, action po-
tential firing is impaired in Purkinje cells (Raman et al.,
1997). Similarly in cerebellum-specific ankyrin-G knockout
mice, mislocalization of VGSC to AIS is associated with the
impaired action potential firing in Purkinje cells (Zhou et
al., 1998). As ankyrin-G is not correctly localized to AIS in
the   IV-spectrin mutant, localization of other ankyrin-G-
binding membrane proteins such as neurofascin and Nr-
CAM is also likely to be affected. Therefore, the possibility
that mislocalization of these proteins also contributes to the
phenotype cannot be excluded. In this context, it will be in-
teresting to compare the  IV-spectrin mutant phenotype
with that of the NrCAM knockout mice, in which a possible
defect in AIS and NR has not been examined yet (Moré et
al., 2001).
Figure 8. Localization of  IV-spectrin at AIS of ankyrin-G–null neurons. Cerebellum (A, A , B, and B ) and hippocampus (C and C ) of 
wild-type (A and A ) and cerebellum-specific ankyrin-G– null (B, B , C, and C ) mice were stained with anti–ankyrin-G (A, B, and C) and 
anti– IV-spectrin (A , B , and C ) antibodies. In D and E, Purkinje cells from wild-type (D) and ankyrin-G–null (E) mice were double stained 
for bIV-spectrin (red) and calbindin D-28K (green), and are shown at higher magnification. The granular layer (G), Purkinje cell layer (P), and 
molecular layer (M) of the cerebellum are separated by dotted lines (A, A , B, and B ). Purkinje cell bodies (Pu) are indicated in (D) and (E). 
Arrowheads indicate AIS of Purkinje cells (A, A , and D). In B and B , the contours of Purkinje cell bodies were observed in the absence of 
specific staining in the mutant due to background staining. Mice were killed at 5 wk of age. Bars, 50  m.346 The Journal of Cell Biology | Volume 156, Number 2, 2002
Although disruption of the ankyrin-G gene is restricted to
the cerebellum in the mutant mice generated by Zhou et al.
(1998), the resulting phenotype is more severe than that ob-
served in our  IV-spectrin mutant. The ankyrin-G mutant
mice frequently fall down when prodded to walk, and in
some cases exhibit premature death following uncontrollable
jumping and convulsions (Zhou et al., 1998). These pheno-
types were not observed in the  IV-spectrin mutant. Faint
ankyrin-G and Nav1.6 staining at AIS in some Purkinje cells
of the  IV-spectrin mutant might indicate that the milder
phenotype is due to the trace amount of VGSC remaining
in cerebellar neurons. Taking into account the fact that the
Nav1.6-null mice die before 4 wk of age due to muscular at-
rophy (Duchen and Stefani, 1971; Burgess et al., 1995), in-
complete mislocalization of VGSC associated with relatively
mild phenotype in the  IV-spectrin mutant is likely.
Role for  IV-spectrin in membrane protein clustering 
at AIS and NR
Mislocalization of ankyrin-G and VGSC in the  IV-spectrin
mutant raises the question of whether  IV-spectrin is re-
quired for targeting these membrane proteins to AIS and
NR or for stabilizing their localization at these sites. The ob-
servation that some ankyrin-G and VGSC labeling still oc-
curs in some AIS and NR in the mutant tends to support the
latter, although it is also possible that trace amounts of other
 -spectrins at AIS and NR partially compensate for  IV-
spectrin function. The increased severity of the  IV-spectrin
mutant phenotype with age is also consistent with the role
for  IV-spectrin in stabilizing the membrane protein clus-
ter. Conversely,  IV-spectrin was also excluded from AIS of
Purkinje cells in region-specific ankyrin-G knockout mice,
suggesting that ankyrin-G in turn stabilizes the  IV-spectrin
localization at these sites. High binding affinity between
 IV-spectrin and ankyrin-G, as shown by coimmunoprecip-
itation experiments, must underlie this mutual stabilization.
As  IV-spectrin localization to AIS was almost completely
disrupted in the ankyrin-G mutant, ankyrin-G may also play
a role in targeting  IV-spectrin to AIS and NR during de-
velopment of neurons. Initial clustering of ankyrin-G at
these sites is thought to be regulated by other axonal pro-
teins such as VGSC, neurofascin, or NrCAM, that are al-
ready clustered at these sites by a glial signal (for review see
Peles and Salzer, 2000; Rasband and Trimmer, 2001).
Therefore, it is possible that ankyrin-G, which is recruited to
these sites by other membrane proteins, recruits  IV-spec-
trin, and once  IV-spectrin forms a complex with the mem-
brane proteins, it in turn serves to stabilize the protein clus-
tering at these sites.
 IV-spectrin has a variable region between the spectrin re-
peat 17 and the PH domain. This domain was termed ER-
QES domain because it contains four repeats of those five
amino acid residues in human (Berghs et al., 2000). This
domain ( 300 amino acids) is much larger than the corre-
sponding regions of other  -spectrins ( 100 amino acids)
and it is rich in proline (15%) and positively (20%), and
negatively charged (16%) residues. This domain has no se-
quence homology to any other proteins including other
 -spectrins in databases, suggesting that it has a function
specific to  IV-spectrin. One possibility is that it serves as an
interaction domain with an unknown protein to regulate
protein clustering at AIS and NR.
The major  IV-spectrin isoform,  6
In this study, we cloned cDNAs encoding two splice iso-
forms for  IV-spectrin,  1 and  6, from three independent
libraries. The  1 isoform is a full-length type consisting of
an actin-binding domain, 17 spectrin repeats, a variable re-
gion, and a PH domain, and has been reported previously in
human (Berghs et al., 2000; Tse et al., 2001). The other iso-
form,  6, is an NH2-terminal truncation lacking the actin-
binding domain and the spectrin repeats 1–9 and a part of
10. Although various splice isoforms have been reported for
other  -spectrins, this type has not been identified, suggest-
ing that this is a unique isoform for  IV-spectrin. Other
groups have identified four additional  IV-spectrin isoforms
( 2– 5) in human (Berghs et al., 2000; Tse et al., 2001). It
is noteworthy that among these isoforms,  6 appears to be
the major isoform at least in the brain, as the size of the  6
cDNA (4.7 kb) and its protein product (141 kD) roughly
correspond to that of the major bands in Northern blotting
( 5 kb) and in Western blotting ( 160 kD), respectively.
On the contrary, the size of mRNAs encoding  2,  3, and
 4 are much larger than 5 kb ( 9 kb) (Berghs et al., 2000),
whereas the size of mRNA encoding  5 is expected to be
much smaller than 5 kb ( 2.5 kb) (Tse et al., 2001). By
Western blotting with antibodies raised against the variable
region and the COOH-terminal region of  IV-spectrin,
Berghs et al. (2000) also detected two major truncated iso-
forms with similar molecular mass ( IV-spectrin 160 and
140) which were not characterized further. One of these
proteins is likely to be the  6 isoform.
In a classical model of the spectrin-actin membrane skele-
ton, a tetramer consisting of two  - and two  -spectrin mol-
ecules is linked to the actin filament through the actin-bind-
ing domain of  -spectrin (for review see Bennett and
Gilligan, 1993; Winkelmann and Forget, 1993). As  6 lacks
the actin-binding domain as well as part of the spectrin re-
peats, it is unclear how this isoform fits into the model. Al-
though it is impossible to distinguish  1 and  6 in tissues
by immunostaining, as our anti– IV-spectrin antibody rec-
ognizes the variable region, Western blotting suggested that
immunostaining in neurons with the antibody mostly re-
flects the expression of  6. These results indicate an un-
known structure of the membrane skeleton specific for AIS
and NR.
Quivering, a spontaneous mutation in  IV-spectrin 
in mice
The  IV-spectrin gene has been mapped to the human chro-
mosome 19q13.13 and mouse chromosome 7 near the cen-
tromere (Berghs et al., 2000; Tse et al., 2001; unpublished
data). Very recently, Parkinson et al. (2001) reported that
the spontaneous mouse mutation “quivering” (qv), which
has been mapped to chromosome 7 at 14.5 cM from the
centromere (Yoon and Les, 1957), carries a mutation in the
 IV-spectrin gene. Qv is an autosomal recessive mutation
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sive ataxia with hindlimb paralysis, and deafness (Yoon and
Les, 1957) (MGD; http://www.informatics.jax.org). Al-
though we have not examined deafness in our  IV-spectrin
mutant, other neurological phenotypes in the qv/qv mice are
consistent with our findings. The allele of  IV-spectrin that
we have generated is a null allele, based on Northern and
Western blot analyses, whereas at least five of seven known
spontaneous qv mutations are the results of single nucleotide
changes or a small deletion/insertion (Parkinson et al.,
2001). Parkinson et al. (2001) compared three alleles in a
test for auditory brainstem function and suggest that various
mutations may result in different degrees of severity of the
phenotype. Therefore, it will be interesting to perform a mo-
lecular analysis of the different qv alleles (for example, the
 6 isoform can be normally expressed from the qv
lnd allele)
and to compare the phenotypic severity with the allele pre-
sented in this work.
The results presented in our study strongly suggest that
the ROSA62 and the qv/qv phenotype, and the impaired ac-
tion potential firing and propagation in the auditory neu-
rons in the qv/qv mice, are primarily due to mislocalization
of VGSC to AIS and NR. Parkinson et al. (2001) also
showed mislocalization of the potassium channel KCNA1 in
axons of qv/qv mice. However, this is likely to be a second-
ary defect, as KCNA1 is not localized to AIS and NR but to
the juxtaparanodal regions flanking NR by a distinct mech-
anism involving binding to a cell recognition molecule
Caspr2 via an unidentified PDZ domain protein (Wang et
al., 1993; Poliak et al., 1999). The demonstration of an es-
sential role for a region-specific spectrin membrane skeleton
in neurons might provide new insights into the molecular
mechanisms underlying certain neuropathological condi-
tions in human.
Materials and methods
Derivation and genotyping of mice
The ROSA62 mutant ES cell clone was obtained by screening for retinoic
acid–inducible gene trapping as described (Komada et al., 2000). Blasto-
cyst injections were performed using standard procedures. Mice were gen-
otyped by Southern blot analysis using DNAs from tail biopsies (Komada et
al., 2000). DNAs were digested with BamHI and hybridized with a neo
probe. Heterozygotes and homozygotes were distinguished by the inten-
sity of a neo-positive band.
X-gal staining and histology
X-gal staining was performed as described (Komada et al., 2000). For stain-
ing adult tissues, mice were perfused transcardially with 4% formalde-
hyde. Brains and spinal cords were sectioned at 100  m using a vibratome
before staining. After staining, pancreas and testis were embedded in par-
affin, sectioned at 5  m, and counterstained with Nuclear Fast Red.
cDNA cloning and Northern blot analysis
Total RNA was prepared as described (Komada et al., 2000), and poly(A)
 
RNA was purified using oligo(dT)-cellulose. ROSA62– geo* fusion cDNA
was amplified from poly(A)
  RNA of ROSA62 mutant ES cells by 5 -RACE
as described (Hildebrand and Soriano, 1999). The 5 -RACE product was
then used to screen mouse ES cell, embryonic day 15 embryo, and adult
brain libraries to obtain full-length cDNAs. Northern blot analysis was per-
formed using standard procedures.
Generation of antibody, Western blotting,
and immunoprecipitation
A chicken antibody (Aves Lab) was raised against the variable region of
 IV-spectrin (amino acid 2171–2345 of  IV 1-spectrin) which was ex-
pressed in Escherichia coli as a glutathione S-transferase fusion protein. Pu-
rified IgY fraction from immunized chicken was absorbed against the  IV-
spectrin–null brain sliced using a vibratome. For Western blotting, a brain
was homogenized in 1 ml lysis buffer (20 mM Tris-HCl, pH 7.4, 140 mM
NaCl, 1% Nonidet P-40, 1 mM PMSF, and 2  g/ml aprotinin). After re-
moving insoluble materials by low-speed centrifugation (1,000 g for 5
min), 20  l of the lysate was run on SDS-PAGE. After transferring proteins
to a Trans-Blot polyvinylidene difluoride membrane (Bio-Rad Laborato-
ries),  IV-spectrin was detected using the anti– IV-spectrin antibody (1:
400), peroxidase-conjugated anti–chicken IgY antibody (1:10,000; Jackson
ImmunoResearch Laboratories), and the ECL reagent (Amersham Pharma-
cia Biotech).
For coimmunoprecipitation experiments, COS-7 cells were transfected
with Myc- IV 6 together with GFP, AnkG-GFP, or AnkB-GFP, gifts of V.
Bennett (Duke University Medical Center, Durham, NC) using the FuGENE
6 Transfection Reagent (Roche). 2 d after transfection, cells were lysed and
the lysates were immunoprecipitated with anti-Myc antibody 9E10 or anti-
GFP (Molecular Probes). Immunoprecipitates were used for Western blot-
ting with the same antibodies.
Immunofluorescence staining
ES cells were plated on gelatin-coated cover glass, fixed with 4% formal-
dehyde, permeabilized with 0.2% Triton X-100, and stained with the anti–
 IV-spectrin (1:400) together with mouse anti-vinculin antibody (1:400;
Sigma-Aldrich) by standard procedures. For staining F-actin, FITC-conju-
gated phalloidin (Sigma-Aldrich) was included in incubation with second-
ary antibody. Brains and spinal cords were recovered from mice perfused
transcardially with 1% formaldehyde, cryoprotected with 30% sucrose,
embedded in the OCT compound (Tissue Tec), and sectioned at 10  m us-
ing a cryostat. The sections were stained with the anti– IV-spectrin
(1:400), mouse anti–ankyrin-G (1:200), a gift of V. Bennett), mouse anti–
pan-sodium channel (10  g/ml; Sigma-Aldrich), rabbit anti-Nav1.6 (Scn8a)
(10   g/ml; Alomone Labs), and rabbit anti-calbindin D-28K (1:1,000;
Chemicon) antibodies. Secondary antibodies used were Alexa594-conju-
gated anti–chicken IgY, Alexa594-conjugated anti–mouse IgG, Alexa488-
conjugated anti–mouse IgG, and Alexa488-conjugated anti–rabbit IgG an-
tibodies (Molecular Probes). Fluorescent images were captured using a
confocal microscope.
Cerebellum-specific ankyrin-G knockout mice originally generated by
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